$BMR
Beamr Imaging Ltd Stock $bmr

$bmr Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023032036 Filed on April 24, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$2.863M	$2.863M	$3.300M
YoY Change	-13.24%	-13.24%
Cost Of Revenue	$98.00K	$98.00K	$90.00K
YoY Change	8.89%	8.89%
Gross Profit	$2.765M	$2.765M	$3.210M
YoY Change	-13.86%	-13.86%
Gross Profit Margin	96.58%	96.58%	97.27%
Selling, General & Admin	$1.733M	$1.733M	$1.732M
YoY Change	0.06%	0.06%
% of Gross Profit	62.68%	62.68%	53.96%
Research & Development	$2.063M	$2.063M	$2.032M
YoY Change	1.53%	1.53%
% of Gross Profit	74.61%	74.61%	63.3%
Depreciation & Amortization	$13.00K	$28.00K	$193.0K
YoY Change	-93.26%	-85.49%
% of Gross Profit	0.47%	1.01%	6.01%
Operating Expenses	$3.796M	$3.796M	$3.764M
YoY Change	0.85%	0.85%
Operating Profit	-$1.031M	-$1.031M	-$554.0K
YoY Change	86.1%	142.59%
Interest Expense	-$165.0K	-$165.0K	-$475.0K
YoY Change	-65.26%	-65.26%
% of Operating Profit
Other Income/Expense, Net		-$165.0K
YoY Change		-65.26%
Pretax Income	-$1.196M	-$1.196M	-$900.0K
YoY Change	32.89%	32.89%
Income Tax	$52.00K	$52.00K	$52.00K
% Of Pretax Income
Net Earnings	-$1.248M	-$1.248M	-$952.0K
YoY Change	31.09%	31.09%
Net Earnings / Revenue	-43.59%	-43.59%	-28.85%
Basic Earnings Per Share		-$0.48
Diluted Earnings Per Share	-$0.10	-$0.48	-$0.07
COMMON SHARES
Basic Shares Outstanding	10.93M shares	2.579M shares
Diluted Shares Outstanding		2.579M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$693.0K	$693.0K	$1.028M
YoY Change	-32.59%	-32.59%
Cash & Equivalents	$693.0K	$693.0K	$1.028M
Short-Term Investments
Other Short-Term Assets	$64.00K	$64.00K	$66.00K
YoY Change	-3.03%	-3.03%
Inventory
Prepaid Expenses
Receivables	$581.0K	$581.0K	$891.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.338M	$1.338M	$1.985M
YoY Change	-32.59%	-32.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.00K	$15.00K	$21.00K
YoY Change	-28.57%	-28.57%
Goodwill	$4.379M		$4.379M
YoY Change	0.0%
Intangibles	$67.00K		$87.00K
YoY Change	-22.99%
Long-Term Investments
YoY Change
Other Assets	$313.0K	$313.0K	$215.0K
YoY Change	45.58%	45.58%
Total Long-Term Assets	$4.774M	$4.774M	$4.702M
YoY Change	1.53%	1.53%
TOTAL ASSETS
Total Short-Term Assets	$1.338M	$1.338M	$1.985M
Total Long-Term Assets	$4.774M	$4.774M	$4.702M
Total Assets	$6.112M	$6.112M	$6.687M
YoY Change	-8.6%	-8.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$33.00K	$33.00K	$27.00K
YoY Change	22.22%	22.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$330.0K	$0.00	$508.0K
YoY Change	-35.04%
Long-Term Debt Due	$126.0K	$330.0K	$345.0K
YoY Change	-63.48%	-35.04%
Total Short-Term Liabilities	$945.0K	$945.0K	$1.413M
YoY Change	-33.12%	-33.12%
LONG-TERM LIABILITIES
Long-Term Debt	$387.0K	$5.227M
YoY Change		9.58%
Other Long-Term Liabilities	$400.0K	$400.0K	$50.00K
YoY Change	700.0%	700.0%
Total Long-Term Liabilities	$5.627M	$5.627M	$4.820M
YoY Change	16.74%	16.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$945.0K	$945.0K	$1.413M
Total Long-Term Liabilities	$5.627M	$5.627M	$4.820M
Total Liabilities	$6.572M	$6.572M	$6.233M
YoY Change	5.44%	5.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.97M		-$29.72M
YoY Change	4.2%
Common Stock	$51.00K		$51.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$460.0K	-$460.0K	$454.0K
YoY Change
Total Liabilities & Shareholders Equity	$6.112M	$6.112M	$6.687M
YoY Change	-8.6%	-8.6%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$1.248M	-$1.248M	-$952.0K
YoY Change	31.09%	31.09%
Depreciation, Depletion And Amortization	$13.00K	$28.00K	$193.0K
YoY Change	-93.26%	-85.49%
Cash From Operating Activities	-$544.0K	-$645.0K	$569.0K
YoY Change	-195.61%	-213.36%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$2.000K	$4.000K
YoY Change	-50.0%	-50.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$2.000K	-$2.000K	-$4.000K
YoY Change	-50.0%	-50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	860.0K	$312.0K	-141.0K
YoY Change	-709.93%	-321.28%
NET CHANGE
Cash From Operating Activities	-544.0K	-$645.0K	569.0K
Cash From Investing Activities	-2.000K	-$2.000K	-4.000K
Cash From Financing Activities	860.0K	$312.0K	-141.0K
Net Change In Cash	314.0K	-$335.0K	424.0K
YoY Change	-25.94%	-179.01%
FREE CASH FLOW
Cash From Operating Activities	-$544.0K	-$645.0K	$569.0K
Capital Expenditures	$2.000K	$2.000K	$4.000K
Free Cash Flow	-$546.0K	-$647.0K	$565.0K
YoY Change	-196.64%	-214.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	508000	usd
CY2020	bmr	Weighted Average Remaining Contractual Life Exercised WeightedAverageRemainingContractualLifeExercised
CY2020	bmr	Weighted Average Remaining Contractual Life Forfeited Or Expired WeightedAverageRemainingContractualLifeForfeitedOrExpired
CY2021	bmr	Weighted Average Remaining Contractual Life Forfeited Or Expired WeightedAverageRemainingContractualLifeForfeitedOrExpired
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	bmr	Modification Of Terms Relating To Straight Loan ModificationOfTermsRelatingToStraightLoan		usd
CY2020	bmr	Modification Of Terms Relating To Straight Loan ModificationOfTermsRelatingToStraightLoan		usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2019Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities		usd
CY2021	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions		usd
CY2020	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions		usd
CY2021	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount		usd
CY2020	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount		usd
CY2021Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	bmr	Advertising At A Point Of Time Upon Clicks AdvertisingAtAPointOfTimeUponClicks		usd
CY2020	bmr	Advertising At A Point Of Time Upon Clicks AdvertisingAtAPointOfTimeUponClicks		usd
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41523
CY2022	dei	Entity Registrant Name EntityRegistrantName	Beamr Imaging Ltd.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 HaManofim Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Herzeliya
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	4672561
CY2022	dei	Entity Address Country EntityAddressCountry	IL
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Israel
CY2022	dei	Contact Personnel Name ContactPersonnelName	Sharon CarmelChief Executive Officer
CY2022	dei	Security12b Title Security12bTitle	Ordinary shares, par value NIS 0.05 per share
CY2022	dei	Trading Symbol TradingSymbol	BMR
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10932896	shares
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	1375
CY2022	dei	Auditor Name AuditorName	Fahn Kanne & Co. Grant Thornton Israel
CY2022	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1028000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	581000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	891000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	64000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1338000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1985000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	313000	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	215000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	87000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4379000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4379000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4774000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4702000	usd
CY2022Q4	us-gaap	Assets Assets	6112000	usd
CY2021Q4	us-gaap	Assets Assets	6687000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	330000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	508000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	33000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	27000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	31000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	33000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	126000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	345000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	425000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	500000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	945000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1413000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	387000	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	262000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	138000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	50000	usd
CY2022Q4	bmr	Convertible Advanced Investments ConvertibleAdvancedInvestments	4840000	usd
CY2021Q4	bmr	Convertible Advanced Investments ConvertibleAdvancedInvestments	4770000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5627000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4820000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	51000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	51000	usd
CY2022Q4	bmr	Common Stock Value1 CommonStockValue1	5000	usd
CY2021Q4	bmr	Common Stock Value1 CommonStockValue1	5000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6196004	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	6186240	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5714400	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5714400	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5714400	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5714400	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	78000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	78000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30375000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30041000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30969000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29721000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-460000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	454000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6112000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6687000	usd
CY2022	us-gaap	Revenues Revenues	2863000	usd
CY2021	us-gaap	Revenues Revenues	3300000	usd
CY2020	us-gaap	Revenues Revenues	3176000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	98000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	90000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	94000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2765000	usd
CY2021	us-gaap	Gross Profit GrossProfit	3210000	usd
CY2020	us-gaap	Gross Profit GrossProfit	3082000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2063000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2032000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2727000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	905000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	959000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1371000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	828000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	773000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	671000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	129000	usd
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	20000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1031000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-425000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-1667000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	165000	usd
CY2021	us-gaap	Financing Interest Expense FinancingInterestExpense	475000	usd
CY2020	us-gaap	Financing Interest Expense FinancingInterestExpense	697000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1196000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-900000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2364000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	95000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1248000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-952000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2459000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578760	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2578760	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2574814	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	3577000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	120000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-2459000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1249000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	157000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-952000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	454000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	112000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	222000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1248000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-460000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1248000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-952000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-2459000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	679000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	222000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	157000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	120000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14000	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14000	usd
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	12000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	40000	usd
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-70000	usd
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-288000	usd
CY2020	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-436000	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	5000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6000	usd
CY2021	bmr	Modification Of Terms Of Straight Loan ModificationOfTermsOfStraightLoan	-90000	usd
CY2021	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	129000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-310000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-704000	usd
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	113000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	26000	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-366000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	16000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-32000	usd
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	31000	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-177000	usd
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-168000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-75000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	63000	usd
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-258000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-645000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	569000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1020000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	8000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	98000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	215000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	560000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	54000	usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	582000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	500000	usd
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	504000	usd
CY2022	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	10000	usd
CY2021	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	40000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	887000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	115000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	312000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-141000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-418000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-335000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	424000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1437000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1028000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	604000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2041000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	693000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1028000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	604000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	112000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	77000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	90000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	91000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	54000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	99000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30969000	usd
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	54000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	560000	usd
CY2022Q4	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	887000	usd
CY2023Q1	bmr	Public Offering Price PublicOfferingPrice	4
CY2023Q1	bmr	Aggregate Gross Proceeds AggregateGrossProceeds	7800000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<b>Use of estimates in the preparation of financial statements </b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions include (i) revenues recognition; (ii) identification of and measurement of financial instruments in funding transactions; (iii) recoverability of the Company’s goodwill upon subsequent periods (iv) measurement of fair value of equity awards and (v) evaluation of going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: left; text-indent: -1cm"><b> </b></p>
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	64000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	313000	usd
CY2022	bmr	Employee Compensation Percentage EmployeeCompensationPercentage	0.0833	pure
CY2022Q4	us-gaap	Other Receivables OtherReceivables	35000	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	29000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	31000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	33000	usd
CY2021Q4	bmr	Government Authorities Assets GovernmentAuthoritiesAssets	22000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	17000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	11000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.10	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.10	pure
CY2022	bmr	Percentage Of Dividend PercentageOfDividend	1	pure
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	9067438	shares
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	8957327	shares
CY2020Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	8842202	shares
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	32000	usd
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	33000	usd
CY2022Q4	bmr	Government Authorities Assets GovernmentAuthoritiesAssets	15000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	137000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	135000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	114000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21000	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	8000	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	16000	usd
CY2020	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	32000	usd
CY2022Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	3335000	usd
CY2021Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	3335000	usd
CY2022Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	3268000	usd
CY2021Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	3248000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	67000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	87000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	177000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	647000	usd
CY2022Q4	bmr	Derivative Warrant Liabilitysee Note8 DerivativeWarrantLiabilityseeNote8	78000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	822000	usd
CY2022Q4	bmr	Total Gross Consideration TotalGrossConsideration	900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	20000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	47000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.253	pure
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.255	pure
CY2022Q4	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Discount Rate LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate	0.03	pure
CY2021Q4	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Discount Rate LongDurationContractsAssumptionsByProductAndGuaranteeDiscountRate	0.03	pure
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	9764	shares
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.12
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	672000	usd
CY2022	us-gaap	Line Of Credit Facility Collateral Fees Amount LineOfCreditFacilityCollateralFeesAmount	712000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	50000	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	350000	usd
CY2022Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.80	pure
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05	pure
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	5.12
CY2020Q2	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	75000	usd
CY2021Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	54000	usd
CY2021Q4	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.01	pure
CY2021	us-gaap	Other Income OtherIncome	129000	usd
CY2022Q3	bmr	Agreement Amount Received AgreementAmountReceived	3100000	ils
CY2022Q3	bmr	Agreement Amount Received AgreementAmountReceived	900000	usd
CY2022Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	4172760000	ils
CY2022Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	1200000	usd
CY2022Q3	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	330000	usd
CY2022	bmr	Percentage Of Outstanding Repayment And Payment Amount PercentageOfOutstandingRepaymentAndPaymentAmount	0.50	pure
CY2022	bmr	Percentage Of Discount Outstanding PercentageOfDiscountOutstanding	0.35	pure
CY2022	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	13000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	65563	shares
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	10000	usd
CY2022Q4	us-gaap	Lessee Finance Lease Discount Rate LesseeFinanceLeaseDiscountRate	0.20	pure
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	62500000	usd
CY2022Q4	us-gaap	Loans Held For Sale Term LoansHeldForSaleTerm	P10Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	1000	usd
CY2022	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	12000000	usd
CY2022	bmr	Reconciliation Of The Carrying Amount ReconciliationOfTheCarryingAmount	508000	usd
CY2021	bmr	Reconciliation Of The Carrying Amount ReconciliationOfTheCarryingAmount	1069000	usd
CY2020	bmr	Reconciliation Of The Carrying Amount ReconciliationOfTheCarryingAmount	1469000	usd
CY2021	bmr	Consideration Received From Ppp Note ConsiderationReceivedFromPPPNote	54000	usd
CY2020	bmr	Consideration Received From Ppp Note ConsiderationReceivedFromPPPNote	75000	usd
CY2022	bmr	Net Consideration Received From Ibi Loan NetConsiderationReceivedFromIBILoan	887000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	88000	usd
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	129000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	14000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	14000	usd
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	29000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	77000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	45000	usd
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	91000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	77000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	45000	usd
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	91000	usd
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee	10000	usd
CY2021	us-gaap	Loan Processing Fee LoanProcessingFee	40000	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	582000	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	500000	usd
CY2020	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	504000	usd
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	672000	usd
CY2021	bmr	Recognition Subsequent To Substantial Modification Of Terms RecognitionSubsequentToSubstantialModificationOfTerms	712000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	12000	usd
CY2022	bmr	Reconciliation Of Carrying Amount ReconciliationOfCarryingAmount	717000	usd
CY2021	bmr	Reconciliation Of Carrying Amount ReconciliationOfCarryingAmount	508000	usd
CY2020	bmr	Reconciliation Of Carrying Amount ReconciliationOfCarryingAmount	1069000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	164000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	288000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	265000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	717000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	508000	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	330000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	298000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	341000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	85000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	126000	usd
CY2022Q4	bmr	Government Authorities GovernmentAuthorities	42000	usd
CY2021Q4	bmr	Government Authorities GovernmentAuthorities	33000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	425000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	500000	usd
CY2022Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	11000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	50000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	50000	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	88000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	138000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	50000	usd
CY2022	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	2	pure
CY2022	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.80	pure
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	4770000	usd
CY2020Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3922000	usd
CY2019Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3486000	usd
CY2021	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	560000	usd
CY2022	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	70000	usd
CY2021	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	288000	usd
CY2020	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	436000	usd
CY2022Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	4840000	usd
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	4770000	usd
CY2020Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	3922000	usd
	us-gaap	Payments For Rent PaymentsForRent	18000	ils
	us-gaap	Payments For Rent PaymentsForRent	5600	usd
	us-gaap	Payments For Fees PaymentsForFees	17000	ils
	us-gaap	Payments For Fees PaymentsForFees	5300	usd
	us-gaap	Payments For Fees PaymentsForFees	21000	ils
	us-gaap	Payments For Fees PaymentsForFees	6500	usd
	us-gaap	Payments For Fees PaymentsForFees	23000	ils
	us-gaap	Payments For Fees PaymentsForFees	7400	usd
CY2022Q3	us-gaap	Payments For Fees PaymentsForFees	3000	usd
CY2022Q4	bmr	Lessee Operating Leases Liability Payments Due Next Twelve Months LesseeOperatingLeasesLiabilityPaymentsDueNextTwelveMonths	77000	usd
CY2022Q4	bmr	Lessee Operating Leases Liability Payments Due LesseeOperatingLeasesLiabilityPaymentsDue	77000	usd
CY2022	us-gaap	Lease Cost LeaseCost	119000	usd
CY2021	us-gaap	Lease Cost LeaseCost	115000	usd
CY2020	us-gaap	Lease Cost LeaseCost	167000	usd
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	22000000	shares
CY2022Q4	bmr	Excess Shares Issued And Outstanding Shares ExcessSharesIssuedAndOutstandingShares	9790040	shares
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	22000000	shares
CY2021Q4	bmr	Excess Shares Issued And Outstanding Shares ExcessSharesIssuedAndOutstandingShares	9790040	shares
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	1.2
CY2021	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	33785000	usd
CY2022	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	33785000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	50000000	usd
CY2022	bmr	Voluntary Conversion Description VoluntaryConversionDescription	subject to the listing of the Company’s Ordinary Shares on Nasdaq, the voluntary conversion of all the Ordinary 1, Ordinary 2, Preferred B, Preferred B-1 and Preferred B shares of the Company into Ordinary Shares (collectively, the “Voluntary Conversion”), (ii) subject to the listing of the Company’s Ordinary Shares on Nasdaq, a reverse share split of all outstanding Ordinary Shares of the Company at a ratio of 5:1 so that each 5 ordinary shares nominal value NIS 0.01 each shall be consolidated into 1 Ordinary Share each, and (the “Reverse Share Split”) (iii) subject to the listing of the Company’s Ordinary Shares on Nasdaq, the recapitalization and redistribution of the entire share capital of the Company (the “Recapitalization”), so that following such Voluntary Conversion and Recapitalization, the share capital of the Company shall consist of NIS 11,100,000 divided into 222,000,000 Ordinary Shares each of which 9,790,040 are issued and outstanding (post the aforesaid Reverse Share Split).
CY2022Q4	bmr	Ordinary Shares Subject To Adjustments OrdinarySharesSubjectToAdjustments	2069280	shares
CY2022Q4	bmr	Ordinary Shares Available For Future Issuance OrdinarySharesAvailableForFutureIssuance	355530	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1291810	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.65
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y11M8D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	194000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	353960	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
CY2020	bmr	Weighted Average Remaining Contractual Life Granted WeightedAverageRemainingContractualLifeGranted	P9Y4M6D
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9800	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.15
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	381970	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.75
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1254000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.7
CY2020	bmr	Weighted Average Remaining Contractual Life Outstanding WeightedAverageRemainingContractualLifeOutstanding	P6Y1M13D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	125000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	839665	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.5
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P4Y8M23D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	252000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1254000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.7
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y1M13D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	125000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	214688	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.05
CY2021	bmr	Weighted Average Remaining Contractual Life Granted WeightedAverageRemainingContractualLifeGranted	P9Y7M20D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	101520	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.8
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1367168	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.75
CY2021	bmr	Weighted Average Remaining Contractual Life Outstanding WeightedAverageRemainingContractualLifeOutstanding	P5Y8M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4860000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	927988	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.6
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P4Y3M
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3429000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1367168	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.75
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y8M19D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4860000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	286875	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.83
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	83052	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.45
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1570991	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.78
CY2022	bmr	Weighted Average Remaining Contractual Life Outstanding WeightedAverageRemainingContractualLifeOutstanding	P4Y11M19D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2435000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1048297	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.7
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1677000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.51
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.44
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.2
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	9800	shares
CY2020Q4	bmr	Total Consideration TotalConsideration	11000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6149	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6475	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0009	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.83
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.8
CY2022Q4	us-gaap	Share Price SharePrice	3.3
CY2021Q4	us-gaap	Share Price SharePrice	3.2
CY2020Q4	us-gaap	Share Price SharePrice	1.8
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1029000	usd
CY2022	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P1Y8M19D
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	144000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	94000	usd
CY2020	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	60000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	49000	usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	45000	usd
CY2020	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	48000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	29000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	18000	usd
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	12000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	222000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	157000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	120000	usd
CY2022	bmr	Financing Expenses FinancingExpenses	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b>NOTE 13 - FINANCING EXPENSES, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: left; text-indent: -63.8pt"><b> </b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Year ended December 31</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Change in fair value of convertible advance investment (see Note 9)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">70</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">288</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">436</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount and accrued interest relating to straight loan received from commercial Bank (see Note 6 and Note 7)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">102</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">59</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">120</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Modification of terms relating to straight loan (see Note 6A1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">90</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Amortization of discount relating to liability to related party (see Note 14)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">40</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exchange rate differences and others</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(47</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">38</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">141</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">165</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">475</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">697</td> <td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2022	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	70000	usd
CY2021	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	288000	usd
CY2020	bmr	Change In The Fair Value Of Convertible Advance Investments ChangeInTheFairValueOfConvertibleAdvanceInvestments	436000	usd
CY2022	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Accrued Interest PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest	102000	usd
CY2021	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Accrued Interest PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest	59000	usd
CY2020	us-gaap	Present Value Of Future Insurance Profits Amortization Expense Accrued Interest PresentValueOfFutureInsuranceProfitsAmortizationExpenseAccruedInterest	120000	usd
CY2021	bmr	Modification Of Terms Relating To Straight Loan ModificationOfTermsRelatingToStraightLoan	90000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	40000	usd
CY2022	bmr	Exchange Rate Differences And Others ExchangeRateDifferencesAndOthers	-47000	usd
CY2021	bmr	Exchange Rate Differences And Others ExchangeRateDifferencesAndOthers	38000	usd
CY2020	bmr	Exchange Rate Differences And Others ExchangeRateDifferencesAndOthers	141000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	165000	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	475000	usd
CY2020	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	697000	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	45000	ils
CY2020Q1	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	357000	usd
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.1545	pure
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	112000	usd
CY2021Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	345000	usd
CY2020Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	168000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	115000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	177000	usd
CY2020Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	168000	usd
CY2022	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	112000	usd
CY2022	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	40000	usd
CY2022Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	388000	usd
CY2021Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	345000	usd
CY2020Q4	us-gaap	Investment Related Liabilities InvestmentRelatedLiabilities	168000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	126000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	345000	usd
CY2022Q4	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	262000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	388000	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	345000	usd
CY2021	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	177000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	42000	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	44000	usd
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	82000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	42000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	44000	usd
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	58000	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	83000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	89000	usd
CY2020	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	108000	usd
CY2022	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	167000	usd
CY2020	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	248000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings	0.23	pure
CY2022	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	27169000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	409000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1293000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1104000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	2529000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-97000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-204000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-165000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1196000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	900000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2364000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6343000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6254000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	438000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	588000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	48000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	62000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6829000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6904000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6829000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6904000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.044	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.058	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.04	pure
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Revenues Revenues	2863000	usd
CY2021	us-gaap	Revenues Revenues	3300000	usd
CY2020	us-gaap	Revenues Revenues	3176000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	15000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	21000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.26	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.23	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.23	pure
CY2022	bmr	Trade Receivables Income Tax Rate TradeReceivablesIncomeTaxRate	0.28	pure
CY2021	bmr	Trade Receivables Income Tax Rate TradeReceivablesIncomeTaxRate	0.44	pure
CY2022	us-gaap	Payments For Software PaymentsForSoftware	2740000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	3188000	usd
CY2020	us-gaap	Payments For Software PaymentsForSoftware	3019000	usd
CY2022	bmr	Pcs Services Transferred Over A Period PCSServicesTransferredOverAPeriod	123000	usd
CY2021	bmr	Pcs Services Transferred Over A Period PCSServicesTransferredOverAPeriod	112000	usd
CY2020	bmr	Pcs Services Transferred Over A Period PCSServicesTransferredOverAPeriod	157000	usd
CY2022	bmr	Advertising At A Point Of Time Upon Clicks AdvertisingAtAPointOfTimeUponClicks	42000	usd
CY2022	bmr	Recognitionof Revenue RecognitionofRevenue	2863000	usd
CY2021	bmr	Recognitionof Revenue RecognitionofRevenue	3300000	usd
CY2020	bmr	Recognitionof Revenue RecognitionofRevenue	3176000	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	48000	usd
CY2021	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	45000	usd
CY2020	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	99000	usd
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001899005
CY2020	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1		usd
CY2022	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	In addition, the Company granted the underwriters (i) 97,500 warrants which shall be exercisable into Ordinary Shares of the Company at an exercise price of $5.00 per Ordinary Share over a period of 5-years commencing August 26, 2023 and (ii) a 45-day option to purchase up to an additional 292,500 ordinary shares at the public offering price less discounts, to cover over-allotments.
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.05
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.05
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2574814	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578760	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2578760	shares
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	bmr	Consideration Received From Ppp Note ConsiderationReceivedFromPPPNote		usd
CY2021	bmr	Net Consideration Received From Ibi Loan NetConsiderationReceivedFromIBILoan		usd
CY2020	bmr	Net Consideration Received From Ibi Loan NetConsiderationReceivedFromIBILoan		usd
CY2021Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral		usd
CY2020Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral		usd
CY2022	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		usd
CY2020	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness		usd
CY2020	us-gaap	Loan Processing Fee LoanProcessingFee		usd
CY2022	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2020	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2022	bmr	Recognition Subsequent To Substantial Modification Of Terms RecognitionSubsequentToSubstantialModificationOfTerms		usd
CY2020	bmr	Recognition Subsequent To Substantial Modification Of Terms RecognitionSubsequentToSubstantialModificationOfTerms		usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential		usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential		usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree		usd
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet		usd
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1		usd

Files In Submission

Name	View Source	Status
0001213900-23-032036-index-headers.html	Edgar Link	pending
0001213900-23-032036-index.html	Edgar Link	pending
0001213900-23-032036.txt	Edgar Link	pending
0001213900-23-032036-xbrl.zip	Edgar Link	pending
bmr-20221231.xsd	Edgar Link	pending
f20f2022ex12-1_beamrimaging.htm	Edgar Link	pending
f20f2022ex12-2_beamrimaging.htm	Edgar Link	pending
f20f2022ex13-1_beamrimaging.htm	Edgar Link	pending
f20f2022ex13-2_beamrimaging.htm	Edgar Link	pending
f20f2022ex2-1_beamrimaging.htm	Edgar Link	pending
f20f2022_beamrimaging.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
bmr-20221231_cal.xml	Edgar Link	unprocessable
bmr-20221231_pre.xml	Edgar Link	unprocessable
bmr-20221231_lab.xml	Edgar Link	unprocessable
bmr-20221231_def.xml	Edgar Link	unprocessable
f20f2022_beamrimaging_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BMR
Beamr Imaging Ltd Stock $bmr

2022 Q4 Form 20-F Financial Statement

#000121390023032036 Filed on April 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BMR Beamr Imaging Ltd Stock $bmr

2022 Q4 Form 20-F Financial Statement

#000121390023032036 Filed on April 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BMR
Beamr Imaging Ltd Stock $bmr